Decolonizing drug policy

Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.

Show simple item record

dc.contributor.author Daniels, Colleen
dc.contributor.author Aluso, Aggrey
dc.contributor.author Burke‑Shyne, Naomi
dc.contributor.author Koram, Kojo
dc.contributor.author Rajagopalan, Suchitra
dc.contributor.author Robinson, Imani
dc.contributor.author Shelly, Shaun
dc.contributor.author Shirley‑Beavan, Sam
dc.contributor.author Tandon, Tripti
dc.date.accessioned 2022-08-16T13:16:22Z
dc.date.available 2022-08-16T13:16:22Z
dc.date.issued 2021-11-27
dc.description.abstract This paper reviews evidence of how drug control has been used to uphold colonial power structures in select countries. It demonstrates the racist and xenophobic impact of drug control policy and proposes a path to move beyond oppressive systems and structures. The ‘colonization of drug control’ refers to the use of drug control by states in Europe and America to advance and sustain the systematic exploitation of people, land and resources and the racialized hierarchies, which were established under colonial control and continue to dominate today. Globally, Black, Brown and Indigenous peoples are disproportionately targeted for drug law enforcement and face discrimination across the criminal system. These communities face higher arrest, prosecution and incarceration rates for drug offenses than other communities, such as majority populations, despite similar rates of drug use and selling among (and between) different races. Current drug policies have contributed to an increase in drug-related deaths, overdoses and sustained transnational criminal enterprises at the expense of the lives of people who use drugs, their families and greater society. This review provides further evidence of the need to reform the current system. It outlines a three-pillared approach to rebuilding drug policy in a way that supports health, dignity and human rights, consisting of: (1) the decriminalization of drugs and their use; (2) an end to the mass incarceration of people who use drugs; (3) the redirection of funding away from ineffective and punitive drug control and toward health and social programs. en_US
dc.description.department Family Medicine en_US
dc.description.librarian am2022 en_US
dc.description.uri http://www.harmreductionjournal.com en_US
dc.identifier.citation Daniels, C., Aluso, A., Burke-Shyne, N. et al. 2021, 'Decolonizing drug policy', Harm Reduction Journal, vol. 18, art. 120, pp. 1-8, doi : 10.1186/s12954-021-00564-7. en_US
dc.identifier.issn 1477-7517
dc.identifier.other 10.1186/s12954-021-00564-7
dc.identifier.uri https://repository.up.ac.za/handle/2263/86812
dc.language.iso en en_US
dc.publisher BMC en_US
dc.rights © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License. en_US
dc.subject War on drugs en_US
dc.subject Drug control policy en_US
dc.subject Human rights en_US
dc.title Decolonizing drug policy en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record